Percutaneous Transluminal Coronary Angioplasty (PTCA) Dilation Catheters Market Report 2026

Percutaneous Transluminal Coronary Angioplasty (PTCA) Dilation Catheters Market Overview

• Percutaneous Transluminal Coronary Angioplasty (PTCA) Dilation Catheters market size has reached to $1.95 billion in 2025 • Expected to grow to $2.68 billion in 2030 at a compound annual growth rate (CAGR) of 6.4% • Growth Driver: Rising Cardiovascular Disease Prevalence To Drive Growth In Percutaneous Transluminal Coronary Angioplasty Dilation Catheters Market • Market Trend: Development Of Dilation Catheter With Advanced Pressure Resistance • North America was the largest region in 2025.

What Is Covered Under Percutaneous Transluminal Coronary Angioplasty (PTCA) Dilation Catheters Market?

Percutaneous transluminal coronary angioplasty (PTCA) dilation catheters are medical devices used to open narrowed or blocked coronary arteries. They involve inserting a catheter with a small balloon at its tip into the artery, then inflating the balloon to widen the artery and improve blood flow. This minimally invasive procedure helps restore proper circulation to the heart. The main types of percutaneous transluminal coronary angioplasty (PTCA) dilation catheters are semi-compliant and non-compliant. Semi-compliant PTCA catheters are designed to expand under pressure while maintaining a certain level of compliance. This characteristic allows them to adapt to the vessel's anatomy, providing effective dilation while minimizing the risk of vessel trauma. These are made of various materials, such as polyurethane, nylon, and others, for a variety of applications, such as hospitals, medical research institutes, and others.

What Is The Percutaneous Transluminal Coronary Angioplasty (PTCA) Dilation Catheters Market Growth Forecast?

The percutaneous transluminal coronary angioplasty (ptca) dilation catheters market size is expected to see strong growth in the next few years. It will grow to $2.68 billion in 2030 at a compound annual growth rate (CAGR) of 6.4%. The growth in the forecast period can be attributed to growth in cardiovascular interventions, emerging market healthcare investments, innovation in catheter materials, increasing clinical expertise, adoption of precision cardiology. Major trends in the forecast period include increasing preference for minimally invasive procedures, growing use of high-pressure non-compliant catheters, demand for improved balloon material durability, expansion of cath lab infrastructure, focus on procedural success rate improvement.

Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Dilation Catheters Market Segmentation

1) By Type: Semi-Compliant Type, Non-Compliant Type 2) By Material Type: Polyurethane, Nylon, Other Material Types 3) By Application: Hospitals, Medical Research Institute, Other Applications Subsegments: 1) By Semi-Compliant Type: Standard Semi-Compliant Catheters, Specialized Semi-Compliant Catheters 2) By Non-Compliant Type: Standard Non-Compliant Catheters, High-Pressure Non-Compliant Catheters

What Is The Driver Of The Percutaneous Transluminal Coronary Angioplasty (PTCA) Dilation Catheters Market?

The increase in cardiovascular diseases is expected to propel the growth of the percutaneous transluminal coronary angioplasty (PTCA) dilation catheters market going forward. Cardiovascular diseases are rising due to lifestyle factors such as poor diet, lack of exercise, and increased stress, along with an aging global population. Percutaneous transluminal coronary angioplasty dilation catheters are used in cardiovascular diseases to open narrowed or blocked coronary arteries, restoring blood flow to the heart. For instance, in June 2024, the American Heart Association, a US-based public health organization that supports cardiovascular medical research, reported that 45 million adults in the USA are expected to have some form of cardiovascular disease by 2050, up from 28 million in 2020. This projection includes significant increases in hypertension, expected to rise from 51.2% to 61.0%, and obesity, projected to grow from 43.1% to 60.6%. Therefore, the increase in cardiovascular diseases is driving the growth of the percutaneous transluminal coronary angioplasty (PTCA) dilation catheters industry.

Key Players In The Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Dilation Catheters Market

Major companies operating in the percutaneous transluminal coronary angioplasty (ptca) dilation catheters market are Cardinal Health Inc., Abbott Laboratories, Medtronic plc, Koninklijke Philips N.V., Becton Dickinson and Company, Boston Scientific Corporation, B. Braun Melsungen AG, Terumo Corporation, Nipro Corporation, Teleflex Incorporated, Lepu Medical Technology (Beijing) Co Ltd., Merit Medical Systems Inc., Cordis Corporation, MicroPort Scientific Corporation, Biosensors International Group Ltd., Alvimedica Medical Technologies, BrosMed Medical Co Ltd., iVascular SLU, Hexacath, Translumina Therapeutics LLP, Eurocor Tech GmbH, GADA S.p.A., Invamed Group

Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Dilation Catheters Market Trends and Insights

Major companies in the percutaneous transluminal coronary angioplasty (PTCA) dilation catheters market are focusing on developing advanced products such as dilation catheters with twin-wall technology to enhance balloon strength and effective artery dilation. Dilation catheters with twin-wall technology are medical devices designed to perform precise and controlled dilation procedures. They feature a unique construction with two concentric layers, or walls, that enhance the catheter's strength, flexibility, and durability. For instance, in February 2023, SIS Medical AG, a Switzerland-based medical device company, launched the OPN NC percutaneous transluminal coronary angioplasty (PTCA) dilatation catheter with Twin-Wall technology in the USA. This catheter offers super high-pressure resistance with a rated burst pressure of 35 atm and low compliance, making it suitable for post-dilatation of under-expanded stents. This unique design provides exceptional pressure resistance and very low compliance, enabling effective treatment of challenging coronary lesions without the risk of over-dilation.

What Are Latest Mergers And Acquisitions In The Percutaneous Transluminal Coronary Angioplasty (PTCA) Dilation Catheters Market?

In June 2024, Boston Scientific Corporation, a US-based manufacturing company that develops and manufactures medical devices, acquired Silk Road Medical Inc. for an undisclosed amount. Boston Scientific Corporation's acquisition of Silk Road Medical Inc. enhances its capabilities in the vascular and endovascular markets, particularly in carotid artery disease treatment. Silk Road Medical Inc. is a US-based company that manufactures medical equipment.

Regional Outlook

North America was the largest region in the percutaneous transluminal coronary angioplasty dilation catheters market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Percutaneous Transluminal Coronary Angioplasty (PTCA) Dilation Catheters Market?

The percutaneous transluminal coronary angioplasty (PTCA) dilation catheters market consists of sales of balloon catheters, drug-eluting balloon catheters, scoring balloon catheters, and cutting balloon catheters. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.